Ibipinabant

DB12649InvestigationalSmall molecule

Ibipinabant has been used in trials studying the treatment of Obesity and Obesity and Type 2 Diabetes.

Chemical structure of Ibipinabant
Mechanism
Curator reviewed
Formula / weight
C23H20Cl2N4O2S · 487.4 g/mol (avg)
Code names
BMS-646256 · JD 5001 · SLV-319

Resolves to

Compound
UNIIO5CSC6WH1TCAS464213-10-3ChEMBLCHEMBL412262PubChem9826744
Structure
InChIKeyAXJQVVLKUYCICH-OAQYLSRUSA-NSMILESCNC(=NS(=O)(=O)C1=CC=C(Cl)C=C1)N1C[C@@H](C(=N1)C1=CC=C(Cl)C=C1)C1=CC=CC=C1
Targets
P21554CNR1

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
841Drug interactionsStructured to mechanism, not free text
Sign in
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Ibipinabant, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In